February 23, 2018 / 9:00 AM / 3 months ago

BRIEF-Sun Pharmaceutical Industries Says U.S. FDA Issued Form 483 With 3 Observations For Halol Facility

Feb 23 (Reuters) - Sun Pharmaceutical Industries Ltd :

* SUN PHARMACEUTICAL INDUSTRIES -U.S. FDA CONDUCTED GMP INSPECTION OF HALOL FACILITY (GUJARAT, INDIA) FROM FEBRUARY 12-23, 2018

* AT CONCLUSION OF INSPECTION, AGENCY ISSUED A FORM 483, WITH THREE OBSERVATIONS

* SUN PHARMACEUTICAL INDUSTRIES - CO PREPARING RESPONSE TO FDA OBSERVATIONS, TO BE SUBMITTED WITHIN 15 BUSINESS DAYS Source text - bit.ly/2EXxdbY Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below